statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Imunon, Inc. (NASDAQ:IMNN - Free Report) - Investment analysts at HC Wainwright issued their Q1 2024 earnings estimates for Imunon in a research report issued to clients and investors on Monday...

Equities Analysts Issue Forecasts for Imunon, Inc.'s Q1 2024 Earnings (NASDAQ:IMNN)

Imunon, Inc. (NASDAQ:IMNN - Get Free Report) saw a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 449,100 shares, a drop of 8.6% from...

Imunon, Inc. (NASDAQ:IMNN) Short Interest Down 8.6% in March

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Imunon price target raised by $1 at H.C. Wainwright, here's why

Q4 2023 Imunon Inc Earnings Call Transcript

Imunon sees cash runway into 4Q24

Imunon reports 2023 EPS ($2.16) vs. ($5.03) last year

Conference Call Begins Today at 10:00 a.m. Eastern Time LAWRENCEVILLE, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused...

IMUNON Reports 2023 Financial Results and Provides Business Update

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
IMNN stock results show that Imunon beat analyst estimates for earnings per share the fourth quarter of 2023.
The post IMNN Stock...

IMNN Stock Earnings: Imunon Beats EPS for Q4 2023

Imunon, Inc. (IMNN) Q4 2023 Earnings Call Transcript...

Imunon, Inc. (IMNN) Q4 2023 Earnings Call Transcript

Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Volume	1,739.00
52-Wk High	$2.00
52-Wk Low	$0.48

IMNN Imunon Inc

About

Feed

News

Fundamentals